Estrone sulfate (medication)のソースを表示
←
Estrone sulfate (medication)
ナビゲーションに移動
検索に移動
あなたには「このページの編集」を行う権限がありません。理由は以下の通りです:
この操作は、次のグループに属する利用者のみが実行できます:
登録利用者
。
このページのソースの閲覧やコピーができます。
{{Short description|Chemical compound}} {{Use dmy dates|date=August 2018}} {{About|estrone sulfate as a medication|its role as a hormone|Estrone sulfate}} {{Drugbox | Verifiedfields = verified | Watchedfields = verified | verifiedrevid = 443736791 | IUPAC_name = [(8''R'',9''S'',13''S'',14''S'')-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6''H''-cyclopenta[''a'']phenanthren-3-yl] hydrogen sulfate | image = Estrone sulfate.svg | width = 250px | image2 = Estrone sulfate 3D ball.png | width2 = 250px <!--Clinical data--> | tradename = | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | pregnancy_US = <!-- A / B / C / D / X --> | pregnancy_category = | legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration = [[Oral administration|By mouth]], others<ref name="pmid16112947" /><ref name="Drugs@FDA" /><ref name="BruckerKing2015" /> | class = [[Estrogen (medication)|Estrogen]]; [[Estrogen ester]] <!--Pharmacokinetic data--> | bioavailability = | protein_bound = 90%, to [[human serum albumin|albumin]], and not to {{abbrlink|SHBG|sex hormone-binding globulin}}<ref name="Buchsbaum2012">{{cite book| vauthors = Buchsbaum HJ |title=The Menopause|url=https://books.google.com/books?id=z0LuBwAAQBAJ&pg=PA64|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-1-4612-5525-3|pages=63–64}}</ref> | metabolism = [[Desulfation]] (via {{abbrlink|STS|steroid sulfatase}})<ref name="FalconeHurd2013" /> | metabolites = • [[Estrone (medication)|Estrone]]<ref name="pmid16112947" /><br />• [[Estradiol (medication)|Estradiol]]<ref name="pmid16112947" /> | elimination_half-life = 12 hours<ref name="WeckerWatts2009">{{cite book | vauthors = Wecker L, Watts S, Faingold C, Dunaway G, Crespo L |title=Brody's Human Pharmacology |url=https://books.google.com/books?id=kfsrz_-OrMQC&pg=PA456 |date=1 April 2009 |publisher=Elsevier Health Sciences |isbn=978-0-323-07575-6 |pages=456–}}</ref> | excretion = <!--Identifiers--> | CAS_number_Ref = {{cascite|correct|CAS}} | CAS_number = 481-97-0 | CAS_supplemental = <br />438-67-5 ([[sodium]])<br />7280-37-7 ([[piperazine]]) | ATC_prefix = | ATC_suffix = | PubChem = 3001028 | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = DB04574 | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ChemSpiderID = 2272513 | UNII_Ref = {{fdacite|correct|FDA}} | UNII = QTL48N278K | ChEMBL_Ref = {{ebicite|correct|EBI}} | ChEMBL = 494753 | ChEBI_Ref = {{ebicite|correct|EBI}} | ChEBI = 17474 | IUPHAR_ligand = 4749 | synonyms = E1S; Oestrone sulfate; Estrone 3-sulfate; Estra-1,3,5(10)-trien-17-one 3-sulfate <!--Chemical data--> | C=18 | H=22 | O=5 | S=1 | SMILES = O=S(=O)(O)Oc1cc4c(cc1)[C@H]3CC[C@@]2(C(=O)CC[C@H]2[C@@H]3CC4)C | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,18+/m1/s1 | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey = JKKFKPJIXZFSSB-CBZIJGRNSA-N }} '''Estrone sulfate''' ('''E1S''') is an [[estrogen (medication)|estrogen]] medication and naturally occurring [[steroid hormone]].<ref name="pmid16112947">{{cite journal | vauthors = Kuhl H | title = Pharmacology of estrogens and progestogens: influence of different routes of administration | journal = Climacteric | volume = 8 | pages = 3–63 | date = August 2005 | issue = Suppl 1 | pmid = 16112947 | doi = 10.1080/13697130500148875 | s2cid = 24616324 }}</ref> It is used in [[menopausal hormone therapy]] among other indications.<ref name="pmid16112947" /><ref name="Drugs@FDA" /> As the [[sodium]] [[salt (chemistry)|salt]] (sodium estrone sulfate), it is the major estrogen component of [[conjugated estrogens]] (Premarin) and [[esterified estrogens]] (Estratab, Menest).<ref name="pmid16112947" /><ref name="BruckerKing2015">{{cite book| vauthors = Brucker MC, King TL |title=Pharmacology for Women's Health|url=https://books.google.com/books?id=AniUCgAAQBAJ&pg=PA361|date=8 September 2015|publisher=Jones & Bartlett Publishers|isbn=978-1-284-05748-5|pages=361–}}</ref> In addition, E1S is used on its own as the [[piperazine]] salt [[estropipate]] (piperazine estrone sulfate; Ogen).<ref name="pmid16112947" /><ref name="BruckerKing2015" /> The compound also occurs as a major and important [[metabolite]] of [[estradiol (medication)|estradiol]] and [[estrone (medication)|estrone]].<ref name="pmid16112947" /> E1S is most commonly taken [[oral administration|by mouth]], but in the form of Premarin can also be taken by [[parenteral]] routes such as [[transdermal administration|transdermal]], [[vaginal administration|vaginal]], and [[injection (medicine)|injection]].<ref name="pmid16112947" /><ref name="Drugs@FDA">{{cite web | title = Drugs@FDA: FDA Approved Drug Products | publisher = United States Food and Drug Administration | access-date = 19 February 2018 | url = http://www.accessdata.fda.gov/scripts/cder/daf/}}</ref>
Estrone sulfate (medication)
に戻る。
ナビゲーション メニュー
個人用ツール
ログイン
名前空間
ページ
日本語
表示
閲覧
履歴表示
その他
検索
案内
索引
脳科学辞典について
最近完成した項目
編集履歴
執筆にあたって
引用の仕方
著作権について
免責事項
問い合わせ
各学会編集のオンライン用語辞典
About us (in English)
Twitter (BrainScienceBot)
ツール
リンク元
関連ページの更新状況
特別ページ
ページ情報
他のプロジェクト